MUMBAI, India, Aug. 31 -- Intellectual Property India has published a patent application (202644099443 A) filed by C Pavani; Dayananda Sagar Academy Of Technology And; Manash Pratim Bharadwaj; Rumpa Chakraborty; Nilotpal Chakravarty; Biplob Roy; Sumanta Ghosh; and Rahul Maity on August 18, 2026, for Ai-Enabled Voice-Based System For Cardiovascular Risk Assessment And Prediction.
Inventors include C Pavani; Dayananda Sagar Academy Of Technology And; Manash Pratim Bharadwaj; Rumpa Chakraborty; Nilotpal Chakravarty; Biplob Roy; Sumanta Ghosh; and Rahul Maity.
The application for the patent was published on August 28, 2026, under issue no. 35/2026.
Abstract: The present invention relates to an AI-Enabled Voice-Based System for Cardiovascular Risk Assessment and Prediction, designed to provide a non-invasive and accessible approach for preliminary assessment of cardiovascular health using speech signals. The system captures a user's voice through a microphone and processes acoustic characteristics including pitch, frequency, speech rate, intensity, spectral features, and voice-quality parameters. The extracted features are analyzed using artificial intelligence and machine learning models to identify voice patterns associated with potential cardiovascular risk conditions. A feature fusion module combines multiple acoustic characteristics to improve prediction reliability, while an AI-based classification module generates a cardiovascular risk assessment and corresponding confidence score. The system further incorporates an explainability module to identify important voice features contributing to the prediction, thereby improving transparency and user understanding. The assessment results are presented through a digital interface, providing risk indicators and recommendations for further clinical evaluation where required. The proposed system enables rapid, contactless, and cost-effective preliminary cardiovascular risk screening without requiring specialized medical equipment. It can be implemented through smartphones, computers, or connected devices and may support continuous or periodic monitoring. The invention is intended as a screening and decision-support technology and does not replace professional medical diagnosis or clinical testing.
Disclaimer: Curated by HT Syndication.
